These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 4083843)
21. Implants of noninvasive papillary urothelial carcinoma in peritoneum and ileocolonic neobladder: support for "seed and soil" hypothesis of bladder recurrence. Herawi M; Leppert JT; Thomas GV; De Kernion JB; Epstein JI Urology; 2006 Apr; 67(4):746-50. PubMed ID: 16566991 [TBL] [Abstract][Full Text] [Related]
22. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803 [TBL] [Abstract][Full Text] [Related]
23. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
24. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method? Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859 [TBL] [Abstract][Full Text] [Related]
25. [Endoscopic diagnosis and treatment of superficial bladder tumors]. Gattegno B; Chopin D Prog Urol; 2001 Nov; 11(5):1023-30. PubMed ID: 11769072 [No Abstract] [Full Text] [Related]
26. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204 [TBL] [Abstract][Full Text] [Related]
27. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. Yossepowitch O; Dalbagni G J Urol; 2002 Jul; 168(1):61-6. PubMed ID: 12050493 [TBL] [Abstract][Full Text] [Related]
28. [Recurrent urothelial cancer after resection of ureteral carcinoma]. Kong C; Ci J; Liu T Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948 [TBL] [Abstract][Full Text] [Related]
29. The use of lasers in the treatment of bladder cancer. Harty JI J Ky Med Assoc; 1988 Sep; 86(9):511-5. PubMed ID: 3049869 [No Abstract] [Full Text] [Related]
30. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. McKenney JK; Amin MB; Young RH Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056 [TBL] [Abstract][Full Text] [Related]
31. [Transitional cell bladder carcinoma in patients younger than 40 years of age]. Madrid García FJ; Parra Muntaner L; Rivas Escudero JA; Sánchez Sánchez E; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J Arch Esp Urol; 1998 Dec; 51(10):991-4. PubMed ID: 9951121 [TBL] [Abstract][Full Text] [Related]
32. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522 [TBL] [Abstract][Full Text] [Related]
33. Natural history of positive urinary cytology after radical cystectomy. Raj GV; Bochner BH; Serio AM; Vickers A; Donat SM; Herr H; Lin O; Dalbagni G J Urol; 2006 Nov; 176(5):2000-5; discussion 2005. PubMed ID: 17070236 [TBL] [Abstract][Full Text] [Related]
34. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848 [TBL] [Abstract][Full Text] [Related]
36. [Case of sarcomatoid carcinoma of the urinary bladder]. Hosokawa Y; Kuwada M; Kumamoto H; Hayashi Y; Fujimoto K; Hirao Y Hinyokika Kiyo; 2008 Aug; 54(8):561-3. PubMed ID: 18788448 [TBL] [Abstract][Full Text] [Related]
37. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ. Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer. Jancke G; Damm O; Rosell J; Jahnson S Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266 [TBL] [Abstract][Full Text] [Related]
39. Urothelial tumors of the bladder. Androulakakis PA; Davaris P; Karayannis A; Michael V; Aghioutantis C Child Nephrol Urol; 1992; 12(1):32-4. PubMed ID: 1606579 [TBL] [Abstract][Full Text] [Related]
40. [The value of urine phosphohexose isomerase activity in comparison with urine cytology. First diagnosis and tumor after-care in patients with cancer of the urinary bladder]. Voigt W; Rothauge CF; Schäffer R Urologe A; 1994 May; 33(3):235-42. PubMed ID: 8053092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]